These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 26233908)
1. Cytochrome P450-CYP2 Family-Epoxygenase Role in Inflammation and Cancer. Chen C; Wang DW Adv Pharmacol; 2015; 74():193-221. PubMed ID: 26233908 [TBL] [Abstract][Full Text] [Related]
2. CYP epoxygenase derived EETs: from cardiovascular protection to human cancer therapy. Chen C; Wang DW Curr Top Med Chem; 2013; 13(12):1454-69. PubMed ID: 23688135 [TBL] [Abstract][Full Text] [Related]
3. Alteration of cardiac cytochrome P450-mediated arachidonic acid metabolism in response to lipopolysaccharide-induced acute systemic inflammation. Anwar-mohamed A; Zordoky BN; Aboutabl ME; El-Kadi AO Pharmacol Res; 2010 May; 61(5):410-8. PubMed ID: 20045729 [TBL] [Abstract][Full Text] [Related]
4. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders. Shahabi P; Siest G; Meyer UA; Visvikis-Siest S Pharmacol Ther; 2014 Nov; 144(2):134-61. PubMed ID: 24882266 [TBL] [Abstract][Full Text] [Related]
5. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids. Shahabi P; Siest G; Visvikis-siest S Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964 [TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 ω-Hydroxylases in Inflammation and Cancer. Johnson AL; Edson KZ; Totah RA; Rettie AE Adv Pharmacol; 2015; 74():223-62. PubMed ID: 26233909 [TBL] [Abstract][Full Text] [Related]
7. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases. Xu X; Zhang XA; Wang DW Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627 [TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450-derived eicosanoids: the neglected pathway in cancer. Panigrahy D; Kaipainen A; Greene ER; Huang S Cancer Metastasis Rev; 2010 Dec; 29(4):723-35. PubMed ID: 20941528 [TBL] [Abstract][Full Text] [Related]
9. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids. Spiecker M; Liao JK Arch Biochem Biophys; 2005 Jan; 433(2):413-20. PubMed ID: 15581597 [TBL] [Abstract][Full Text] [Related]
10. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. Zordoky BN; El-Kadi AO Pharmacol Ther; 2010 Mar; 125(3):446-63. PubMed ID: 20093140 [TBL] [Abstract][Full Text] [Related]
11. EET signaling in cancer. Panigrahy D; Greene ER; Pozzi A; Wang DW; Zeldin DC Cancer Metastasis Rev; 2011 Dec; 30(3-4):525-40. PubMed ID: 22009066 [TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance. Xu M; Ju W; Hao H; Wang G; Li P Drug Metab Rev; 2013 Aug; 45(3):311-52. PubMed ID: 23865864 [TBL] [Abstract][Full Text] [Related]
14. Role of cytochrome P450 epoxygenase in regulating renal membrane transport and hypertension. Capdevila J; Wang W Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):163-9. PubMed ID: 23302865 [TBL] [Abstract][Full Text] [Related]
15. Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoids. Medhora M; Dhanasekaran A; Gruenloh SK; Dunn LK; Gabrilovich M; Falck JR; Harder DR; Jacobs ER; Pratt PF Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):19-29. PubMed ID: 17164129 [TBL] [Abstract][Full Text] [Related]